Kolexia
Vukusic Sandra
Neurologie
Hôpital Pierre Wertheimer
Bron, France
424 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérose en plaques Sclérose Neuromyélite optique Sclérose en plaques récurrente-rémittente Maladies démyélinisantes Myélite Sclérose en plaques chronique progressive Leucoencéphalopathie multifocale progressive COVID-19

Industries

Biogen
14 collaboration(s)
Dernière en 2023
Novartis
11 collaboration(s)
Dernière en 2023
Merck-Serono
7 collaboration(s)
Dernière en 2021
Janssen
4 collaboration(s)
Dernière en 2023

Dernières activités

Priority setting: women's health topics in multiple sclerosis.
Frontiers in neurology   19 février 2024
VHD cohort: Very High Definition Cohort: Assessment of New Prognostic Biomarkers of Disability Worsening in a Multicenter Cohort of MS Patients by Imaging, Optical Coherence Tomography and Biology
Essai Clinique (EDMUS Foundation)   15 février 2024
Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis.
Neurology(R) neuroimmunology & neuroinflammation   12 février 2024
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
JAMA neurology   12 février 2024
RESPONSE: French Registry for Monitoring Pregnancies and Children of Women With Multiple Sclerosis Within The Observatoire Français de la Sclérose en Plaque (OFSEP) Cohort
Essai Clinique (Hospices Civils de Lyon)   25 janvier 2024
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
Multiple sclerosis (Houndmills, Basingstoke, England)   21 janvier 2024
The Response Study: A French registry on pregnancy in women with MS and related disorders and their children up to 6 years-Protocol, recruitment status, and baseline characteristics.
Multiple sclerosis (Houndmills, Basingstoke, England)   11 janvier 2024
Predictors of treatment switching in the Big Multiple Sclerosis Data Network.
Frontiers in neurology   22 décembre 2023
Pregnancy and Infant Outcomes in Women Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of the Largest Available Outcomes Database
Multiple sclerosis and related disorders   01 décembre 2023
STOP-I-SEP: Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years
Essai Clinique (CHU Rennes)   23 octobre 2023